Tel:028-88610620
Email:pr@keymedbio.com/BD@keymedbio.com
Committed to Providing More High-quality and Affordable Innovative Therapies for Patients in China and around the World
Leading the Development of Innovative Tumor Therapy and Autoimmune Therapy
Keep Pursuing a Higher Standard of Social Value Output
01
02
03
Keymed Biosciences consistently explore the disease areas that need to be solved urgently, focus on the autoimmune and tumor therapies, establish a highly competitive pipeline, and rapidly promote the R&D of multiple innovative drugs.
30+
Projects under R&D
9
Entered Clinical Stage
3
Bispecific Antibody
1
ADC
Meet the GMP Standards of NMPA, FDA and EMA
Efficiently Synthesize the Internal Development and Production Capability, Establish a Comprehensive and Integrated Biological R&D Platform
Innovation Runs through the Whole Industrial Chain of R&D, Production and Future Commercial Operation
Company Profile Management Team Milestones
R&D Center Pipeline Manufacturing Park Cooperation
Corporate Governance Information Disclosure Financial Reports Stock Information IR Calendar Investor Presentations Email Alerts IR Contact
Latest News Media
Culture & Benefits
Contact Information Consultation Legal Statement Privacy
Tel:028-88610620
Email:pr@keymedbio.com/BD@keymedbio.com
蜀ICP备2022006281号